📧 Communication

Guidance Document

← Back to List

Communication Details

From

FDA Linked to FDA

Industry Celebrities in the movie industry

Date

December 01, 2016

Subject

Botanical Drug Development; Guidance for Industry

Message Content

Discusses regulatory policies for botanical drugs.

📄 Source Document

HOUSE_OVERSIGHT_024712.jpg

ESTATE Collection

View Document

Document Summary

Page 76 of a December 2017 Cannabis Investment Report authored by Ackrell Capital. The text analyzes the regulatory landscape for cannabis-based foods and dietary supplements under the FD&C Act, specifically focusing on FDA and DEA policies regarding THC and CBD. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a congressional document production, though no specific individuals (including Epstein) are named on this page.

Discussion 0

No comments yet

Be the first to share your thoughts on this epstein communication